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To maintain appropriate body iron levels, iron
absorption by the proximal duodenum is thought to
be controlled by hepcidin, a polypeptide secreted
by hepatocytes in response to high serum iron. Hep-
cidin limits basolateral iron efflux from the duodenal
epithelium by binding and downregulating the intes-
tinal iron exporter ferroportin. Here, we found that
mice with an intestinal ferritin H gene deletion show
increased body iron stores and transferrin saturation.
As expected for iron-loaded animals, the ferritin
H-deleted mice showed induced liver hepcidin
mRNA levels and reduced duodenal expression of
DMT1 and DcytB mRNA. In spite of these feedback
controls, intestinal ferroportin protein and 59Fe
absorption were increased more than 2-fold in the
deleted mice. Our results demonstrate that hepci-
din-mediated regulation alone is insufficient to
restrict iron absorption and that intestinal ferritin H
is also required to limit iron efflux from intestinal
cells.
INTRODUCTION
Iron absorption by the proximal intestine is strictly controlled in
order to maintain body iron homeostasis (Andrews and Schmidt,
2007; Hentze et al., 2004). Iron enters duodenal enterocytes from
the intestinal lumen by divalent metal transporter 1 (DMT1)-
mediated transport across the apical brush border membrane
after reduction to Fe2+ by duodenal cytochrome b (Dcytb)
(Fleming et al., 1997; Gunshin et al., 1997; McKie et al., 2001).
Its export at the basolateral membrane ismediated by ferroportin
(Donovan et al., 2000; McKie et al., 2000) followed by its reoxida-
tion to Fe3+ by hephaestin (Vulpe et al., 1999). The control of iron
absorption requires hepcidin, a polypeptide hormone secreted
by the liver in response to high body iron levels (Nicolas et al.,
2001; Pigeon et al., 2001) and other systemic stimuli (Nicolas
et al., 2002; Vecchi et al., 2009). Hepcidin binds to ferroportin,
inducing its internalization, which is thought to inactivate cellular
iron export (Nemeth et al., 2004). The importance of hepcidin in
controlling ferroportin function is supported by the observation
that most forms of hereditary hemochromatosis are either linkedCell Meto a dysfunction of hepcidin itself (Roetto et al., 2003) or to
a defect in the signaling pathways that control its expression.
These involve HFE (Feder et al., 1996), transferrin receptor 2
(Camaschella et al., 2000), and hemojuvelin (Babitt et al., 2006;
Niederkofler et al., 2005; Papanikolaou et al., 2004).
Early investigations proposed that the intestinal ferritin content
is involved in the control of intestinal iron absorption by scav-
enging excess nutritional iron in duodenal cells (Conrad and
Crosby, 1963; Granick, 1946; Hahn et al., 1943). Ferritin is
a protein polymer of 24 ferritin H and L subunits forming a hollow
shell structure that can store up to 4500 Fe3+ ions (Harrison and
Arosio, 1996). The polymer exhibits variable stoichiometry of the
two ferritin subunits in different tissues. Only ferritin H has ferrox-
idase activity that is indispensable to store iron in the ferritin
shell. Initial isotope studies on iron absorption revealed that
humans and dogs with chronic iron-deficiency anemia trans-
ported 5–15 times more iron across the duodenal mucosa than
controls, indicating a physiological barrier to iron absorption in
iron-adequate individuals (Hahn et al., 1943). Intestinal iron
absorption rates increased with a delay of several days after
induction of acute anemia by severe bleeding of dogs, suggest-
ing a slow, probably indirect feedback regulation. In contrast,
a single high oral dose of iron sulfate given to anemic animals
1–2 hr before an oral test dose of 59Fe reduced the absorption
of subsequent oral doses (Hahn et al., 1943). This ‘‘mucosal
block’’ lasted for several days after administration of the blocking
dose and correlated with the expression of intestinal ferritin
(Granick, 1946). Autoradiography showed that excessively
absorbed 59Fe3+ was retained in the enterocytes at the tip of
duodenal villi until they were exfoliated into the lumen (Conrad
and Crosby, 1963). Ferritin was considered the most probable
candidate protein for such long-term mucosal iron retention.
The validity of the ‘‘mucosal block’’ concept (Crosby, 1966)
was later questioned, as it was not consistently observed in
the context of iron supplementation schemes in developing
countries when daily and weekly supplementation were com-
pared (Beard, 1998; Beutler, 2002; Hallberg, 1998). However,
the possible role of ferritin in controlling iron absorption was
not adequately addressed at the level of gene expression and
molecular mechanisms.
Recently, we developed a mouse model with a ferritin H allele
carrying loxP sites permitting the conditional deletion of ferritin H
by Cre recombinase (Darshan et al., 2009). In the present study,
we took advantage of a cross between the floxed ferritin H allele
and the transgenic villin-Cre mouse to delete the ferritin H gene
specifically in intestinal cells (el Marjou et al., 2004). The deletiontabolism 12, 273–282, September 8, 2010 ª2010 Elsevier Inc. 273
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Figure 1. Tissue-Specific Deletion of Ferritin H Mediated
by Villin-Cre
(A) Ferritin mRNA expression tested by real-time PCR in total RNA
extracts of duodenum in 10- to 13-week-old control Fthlox/lox and
experimental FthD/D mice (average of four animals per group ±SD;
***p < 0.0005).
(B) Intestinal iron content of control Fthlox/lox and experimental FthD/D
mice measured by the bathophenanthroline method (average of four
animals per group ±SD; ***p < 0.0005).
(C) H&E-stained paraffin sections of intestinal villi of control Fthlox/lox
and experimental FthD/D mice.
(D) Immunostaining with rabbit anti-ferritin H antibody and goat anti-
rabbit IgG-HRP of the same paraffin sections. Scale bar = 50 mm.
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Conditional Ferritin H Deletion in Mouse Intestineis constitutive at birth in Cre-expressing mice, but absent in Cre-
negative littermates. We have compared the iron metabolism in
these two sets of mice at 10–35 weeks of age and show that
the intestine-specific deletion of ferritin H triggers loss of
mucosal iron storage along with increasing serum iron and
body iron load. Although expression of duodenal apical trans-
porters was repressed and liver hepcidin mRNA was induced
in correlation with increased serum iron, these changes were
insufficient to control iron absorption. Ferritin H-deleted animals
showed increased ferroportin expression and enhanced 59Fe
absorption over 7 days after gavage. In consequence, we
propose a revised model for the regulation of iron absorption,
in which mucosal ferritin participates actively and complements
the hepcidin-mediated control of duodenal ferroportin.
RESULTS
Mice with an intestine-specific ferritin H gene deletion were
generated by crossing Fthlox/lox mice (Darshan et al., 2009) with
villin-Cre mice (el Marjou et al., 2004) in a predominantly
C57BL/6J genetic background. Twelve-week old FthD/D mice
expressed less than 0.5% ferritin H mRNA in the intestinal
mucosa compared to nondeleted control Fthlox/lox littermates
(Figure 1A). No morphological changes were observed in
duodenal villi (Figure 1C). Ferritin H protein expression was274 Cell Metabolism 12, 273–282, September 8, 2010 ª2010 Elsevier Inc.consistently reduced in immunological staining of frozen
sections from the duodenum of FthD/D mice (Figure 1D),
and tissue iron content diminished due to the absence
of iron storage capacity (Figure 1B).
At 10–13weeks of age, FthD/Dmice showed a significant
increase in serum iron concentration (Figure 2A) and
transferrin saturation (Figure 2B). Moreover, hepatic
iron accumulation increased on average 1.9 times as
compared to control Fthlox/lox littermates (Figure 2C).
This was not observed in the spleen (Figure 2D). These
parameters showed no difference between females
and males. In agreement with hepatic iron overload,
FthD/Dmice showed on average a 2.4-fold increase in hep-
cidin mRNA (Figure 2E). It is noteworthy that hepcidin
mRNA levels were 1.8-fold higher in females than in
males, independent of the ferritin H deletion status.
Increased hepcidin mRNA levels correlated positively
both with the serum iron concentration and liver iron
content (Figure 2F).Iron accumulated over time in both liver and spleen, with
a more pronounced accumulation in females (Figure 3). This
was observed both in Fthlox/lox and in FthD/D mice. The ratio of
enhanced liver iron accumulation in FthD/D versus Fthlox/lox
mice was 1.5- to 1.8-fold at all ages (Figure 3A). Splenic iron
content was normal in young animals but increased to a 1.8-
fold higher level in 35-week old FthD/D animals, except for 2
out of 6 male FthD/D mice that remained normal (Figure 3B).
Hepcidin mRNA in the liver was consistently higher in FthD/D
versus Fthlox/lox mice at all age groups (Figure 3C), though
values in female FthD/D mice were about 1.8-fold higher than
in male FthD/D mice (Figure 3C). However, in contrast to the
hepatic iron content, hepcidin mRNA did not increase with
age. Serum iron (Figure 3D) and transferrin saturation (Fig-
ure 3E) were always higher in FthD/D versus Fthlox/lox mice,
but did not change significantly with increasing age. These
results suggest that over time hepcidin mRNA levels correlated
directly to serum iron concentrations and transferrin saturation
as has been previously proposed (Lin et al., 2007; Wilkins
et al., 2006).
Taken together, these results indicate that mice with the intes-
tinal ferritin H deletion were unable to maintain their iron homeo-
stasis. We therefore measured whether increased hepcidin
expression correlated with expected changes in iron transport
protein expression. FthD/D mice showed a highly significant
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Figure 2. Serum and Tissue Iron Content Is Increased in FthD/D Mice in Spite of Increased Hepcidin mRNA Levels
(A–D) Control Fthlox/lox and experimental FthD/D mice at 10–13 weeks of age were analyzed for circulating serum iron levels (A), transferrin saturation (B), and
nonheme iron content in liver (C) and spleen (D).
(E) The same mice were analyzed for hepcidin mRNA. Error bars indicate SD. **p < 0.005, ***p < 0.0005.
(F) HepcidinmRNA levels of individual males (B,C) and females (,,-) of Fthlox/lox (B,,) and FthD/D (C,-) micewere correlatedwith their serum and liver iron
levels. Calculated r2 values for the correlation coefficient were 0.314 (n = 16; p < 0.05) and 0.50 (n = 26; p < 0.0005), respectively.
Cell Metabolism
Conditional Ferritin H Deletion in Mouse Intestinerepression in intestinal DMT1 and Dcytb mRNA levels as
compared to control Fthlox/loxmice, but no change was observed
in ferroportin and hephaestin mRNA levels (Figure 4A). As hepci-
din downregulates ferroportin protein by inducing its endocy-
tosis (Nemeth et al., 2004), we also analyzed ferroportin protein
levels in intestinal villi by immunoblotting with anti-ferroportin
antibodies. Both 12- and 35-week old FthD/D mice showed
a consistent high expression of ferroportin, whereas in Fthlox/lox
mice, expression was lower in most animals and more variable
(Figure 4C). Quantification showed a difference of 2.3-fold
(p = 0.14) at 12 weeks and 2.2-fold (p = 0.037) at 35 weeks,
not taking into account one Fthlox/lox mouse in which ferroportin
was undetectable. Immunostaining with anti-ferroportin anti-
bodies of the duodenal sections showed consistently that
the transporter was located at the basolateral membranes of
villi both in Fthlox/lox and in FthD/Dmice (Figure 4D). This indicates
upregulation of duodenal ferroportin in FthD/D mice. The
results predict a diminished iron transport capacity across the
apical membrane but possibly an increased rate of iron export
basolaterally. In view of the increased hepatic and splenic iron
load, this latter finding seemed significant. Therefore, iron
absorption was assessed bymeasuring 59Fe retention in animals
7 days after gavage of a single 59Fe3+ dose. The whole-body
retention of 59Fe was 2.4-fold higher in FthD/D than in Fthlox/lox
mice (Figure 4B). Up to 53% of the absorbed 59Fe was found
deposited in the liver, whereas less than 3.1% remained associ-Cell Meated with the intestine, showing that 59Fe absorption was
complete.
To gain further mechanistic insight into why FthD/D mice are
inefficient in their control of iron transport, we analyzed iron
regulatory protein (IRP) activity in intestinal cells using RNA-
protein gel retardation assays (Figures 5A and 5B). IRP1 and
IRP2 bind iron-responsive elements (IREs) and are both inacti-
vated by increased free cytoplasmic iron (Henderson et al.,
1993). Thus, their IRE-binding activity can be used to assess
the free iron status of a cell. Approximately 10% of the total
IRP1 was spontaneously active in Fthlox/lox mice (Figure 5B),
and we could not observe further inactivation in FthD/D mice.
However, the less abundant IRP2 showed significantly higher
activity in Fthlox/lox than FthD/D mice. This finding suggests an
increased free cytoplasmic iron pool in intestinal cells lacking
ferritin H. To corroborate these findings, we measured steady-
state levels of intestinal transferrin receptor 1 mRNA by real-
time PCR (Figure 5C). Transferrin receptor 1 mRNA is known to
be destabilized when IRPs are inactivated, as IRPs cannot
protect the RNA by binding to the IREs in the 30 untranslated
region (Mu¨llner et al., 1989). Consistent with the above conclu-
sions, intestinal transferrin receptor 1 mRNA levels were dimin-
ished in all FthD/D mice of different age and gender. We also
measured ferritin L protein levels on immunoblots and found
a 1.5-fold increase in FthD/D mice (Figure 5D). This result
supports the finding of increased intracellular free iron, whichtabolism 12, 273–282, September 8, 2010 ª2010 Elsevier Inc. 275
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MalesFemales Figure 3. Enhanced Accumulation of Iron in
Female and Male Mice after Intestinal Ferritin H
Deletion
(A–E) Fthlox/lox and FthD/D mice (light and dark gray,
respectively) were analyzed at different ages for tissue
nonheme iron content in liver (A) and spleen (B), hepcidin
mRNA in liver (C), serum iron (D), and transferrin saturation
(E). Age groups were at 10–18 weeks (n = 3–16),
23–26 weeks (n = 3 for females; n = 2 for males), and
35 weeks (n = 4–6). Error bars indicate SD. *p < 0.05,
**p < 0.005, ***p < 0.0005.
Cell Metabolism
Conditional Ferritin H Deletion in Mouse Intestineinactivates IRP activity and thereby relieves repression of
ferritin L mRNA translation.
As intracellular free iron is likely to provoke oxidative stress,
we measured the expression of genes that usually are upregu-
lated by reactive oxygen species (ROS). Among these, heme-
oxygenase 1 mRNA was on average more than 70-fold induced
(Figure 6). In contrast, mRNA levels of catalase, glutathione
peroxidase 1, and superoxide dismutase 1 showed about a
1.5-fold increase. The data indicate the presence of ROS in
ferritin H-deleted intestinal cells.276 Cell Metabolism 12, 273–282, September 8, 2010 ª2010 Elsevier Inc.DISCUSSION
The present data show that duodenal ferritin is
required for the accurate control of iron absorp-
tion. Mice lacking mucosal ferritin H in the intes-
tine increase their hepatic iron load to an extent
that resembles hereditary hemochromatosis in
the mouse model of Hfe deficiency (Bahram
et al., 1999; Fleming et al., 1999). This effect
was more rapid and stronger in females than in
males.UnlikemicewithHfedeficiency, however,
aging FthD/D mice accumulated iron also in the
spleen. This may relate to the type of mutation
and its local effect on absorptive intestinal cells.
The iron-loaded FthD/D animals induced hepatic
hepcidin expression in good correlation with
increased serum iron and transferrin saturation
(Figure 3) (Lin et al., 2007; Pigeon et al., 2001;
Wilkins et al., 2006). However, unexpectedly,
duodenal FthD/D mice did not respond to
increased hepcidin expression (Nemeth et al.,
2004) and showed higher ferroportin protein
levels than Fthlox/loxmice (Figure 4C). This corre-
lated well with an increased 59Fe absorption
(Figure 4B) and accumulation of tissue iron with
age (Figure 3). It indicates that the hepcidin-
mediated inhibition of iron transport was either
not functional or insufficient to reduce iron
absorption rates in FthD/D mice. We conclude,
therefore, that mucosal ferritin is directly or indi-
rectly involved in limiting iron absorption. Its
function being iron storage, we propose that
ferritin sequesters iron as it passes through
themucosal epithelial cells. This raises the ques-
tion of how the ferritin H deletion modifies the
regulation of iron absorption.Iron absorption across the intestinal mucosa comprises at
least three steps: (1) apical uptake of iron from the lumen, (2)
transfer through the cell cytoplasm with the possibility of being
captured by ferritin, and (3) basolateral export through ferropor-
tin. Normally, each of these steps is regulated in order to fine-
tune iron absorption to body requirements. There is evidence
that the capacity of the uptake and export steps of intestinal
iron transport varies inversely with the state of body iron repletion
and is regulated by the expression and function of iron trans-
porters. Iron repletion and high hepcidin levels strongly reduce
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Figure 4. Increased 59Fe Absorption in FthD/DMice
Correlates with Increased Ferroportin Protein
Expression
(A) mRNA levels of four intestinal iron transport
proteins were measured by RT-PCR in 12-week-old mice
(Fthlox/lox, n = 3; FthD/D, n = 4). Error bars indicate SD.
*p < 0.05, **p < 0.005.
(B) 59Fe absorption was assessed in Fthlox/lox and FthD/D
mice given orally a single dose of 10 mM FeSO4 mixed
with 4 mCi 59Fe3+. The applied 59Fe dose was determined
immediately after gavage. Seven days later, the whole-
body retention of 59Fe had reached steady state and
was expressed as percent ±SD of the initial 59Fe dose.
*p < 0.05.
(C) Immunoblots of ferroportin from intestine of Fthlox/lox
and FthD/Dmice (n = 4 for each) at 12 and 35 weeks of age.
(D) Representative paraffin-embedded intestine sections
of Fthlox/lox and FthD/D mice were stained with anti-ferro-
portin and goat anti-rabbit IgG-HRP antibody. Arrowheads
point at basal and lateral membranes. Scale bar = 50 mm.
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Conditional Ferritin H Deletion in Mouse IntestineDMT1 and Dcytb mRNA expression (Frazer et al., 2002, 2003;
McKie et al., 2001; Zoller et al., 2001). Our present results
show that FthD/D mice exhibit reduced DMT1 and Dcytb mRNA
expression (Figure 4A), exactly as observed in these previous
studies. We therefore believe that the apical uptake of iron in
step 1 is decreased in FthD/D mice and indirectly altered by the
ferritin H deletion, due either to body iron accumulation or, in
the case of DMT1, to IRP inactivation. One of the DMT1 tran-
scripts comprises an IRE that may affect its mRNA stability
(Galy et al., 2008). Two very recent studies have now shown
that the genes for DMT1 and Dcytb are mostly transcriptionally
regulated by the oxygen-sensitive HIF-2a (Mastrogiannaki
et al., 2009; Shah et al., 2009). This transcription factor is hydrox-
ylated by an iron-dependent prolyl-hydroxylase, ubiquitinated
by the E3 ubiquitin ligase von Hippel-Lindau tumor suppressor
(Vhl), and degraded in proteasomes. Most interestingly, disrup-
tion of Vhl makes HIF-2a a predominant inducer of DMT1 and
Dcytb, and this provokes iron overload in spite of increased hep-
cidin expression (Shah et al., 2009). The authors observed an
increased iron deposition in villus epithelial cells, but it seemsCell Metabolism 12, 273the hepcidin-ferroportin barrier is overwhelmed
by the import of too much iron. These results
fit in well with our present observations. Both
sets of results indicate that an effective
control of the duodenal free iron pool is a prereq-
uisite for an effective control of intestinal iron
absorption.
Concerning step 2, it is evident that the dele-
tion of ferritin H will have a direct effect on the
transfer of iron through the cell cytoplasm.
Normally, storage of iron in ferritin may exert
three important functions. First, the iron pool
available for export of iron at the basolateral
side gets reduced; second, storage of intracel-
lular free iron influences IRP activity, which in
turn controls mRNA stability or translation; and
third, keeping the free iron pool low reduces
the formation of ROS.We provide here evidencethat the ferritin H deletion indeed perturbs all three of these
functions. Based on the inactivation of IRP activity and altered
transferrin receptor 1 mRNA and ferritin L protein expression
(Figure 5), we conclude that FthD/Dmice show an increased intra-
cellular free iron pool. This is accompanied by an increased
formation of ROS, as indicated by the induction of heme-oxygen-
ase (Figure 6). Under normal physiological conditions, the
biosynthesis of both ferritin subunits is regulated at the level of
mRNA translation in correlation with available intracellular iron
(as reviewed, e.g., by Hentze and Ku¨hn, 1996). IRPs become
active RNA-binding proteins when the labile intracellular iron
pool is low and repress translation of both ferritin subunits by
binding to IREs in the 50 untranslated regions. In contrast, when
intracellular iron is plentiful, IRPs are inactivated and ferritin trans-
lation is unimpaired. A role of IRPs in translational repression of
intestinal ferritin H and L was recently demonstrated by the
tissue-specific conditional deletion of IRP1 and IRP2, and
expression of both ferritin H and L was strongly increased (Galy
et al., 2008). We have previously shown that duodenal IRP1
activity responds rapidly to dietary iron (Schu¨mann et al., 1999).–282, September 8, 2010 ª2010 Elsevier Inc. 277
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Figure 5. Iron Regulatory Protein Activity, Transferrin Receptor 1 mRNA Levels, and Ferritin L Protein Expression Indicate Enhanced Intra-
cellular Free Iron in the Intestine of FthD/D Mice
(A) IRP1 and IRP2 activity was assessed by RNA-protein gel retardation assays with intestinal protein extracts from Fthlox/lox and FthD/Dmice (n = 3 for each) at two
different concentrations (13 and 83). Preincubation of extracts with 2% b-mercaptoethanol (+b-me) is known to activate all IRP1 proteins, and this total IRP1
activity served as a reference for normalization.
(B) RNA-protein complexes of (A) were quantified by the phosphorimager and normalized to total IRP1 activity. Error bars indicate SD. This showed significantly
diminished IRP2 activity in FthD/D mice. ***p < 0.0005.
(C) Real-time PCR of transferrin receptor 1 mRNA shows a significant and reproducible reduction at different age and sex in FthD/D versus Fthlox/lox mice, indi-
cating a lower mRNA stability after IRP inactivation by increased free iron. Error bars indicate SD. *p < 0.05, **p < 0.005.
(D) Immunoblots of ferritin L from intestine of Fthlox/lox and FthD/D mice (n = 4 for each) at 35 weeks of age.
Cell Metabolism
Conditional Ferritin H Deletion in Mouse IntestineIn addition, it was proposed that crypt cells may sense body iron
stores (Conrad and Crosby, 1963), as their iron supply depends
on serum transferrin. As these cells mature, however, serum
transferrin has poor access, and adjustments of IRPs and ferritin
to body iron are rather ineffective (Granick, 1946; Hahn et al.,
1943; Schu¨mann et al., 1999). Under the present condition of
a ferritin H deletion, all this feedback regulation must be lost.
We expect, therefore, that the duodenal cells of FthD/D mice
can no longer sense and capture iron on its flow through the
cytoplasm, and this causes the increased free iron pool and278 Cell Metabolism 12, 273–282, September 8, 2010 ª2010 ElsevieIRP inactivation. We propose that the increased free iron
pool may then create a steeper concentration gradient, which
enhances the transport rates of basolateral iron efflux through
ferroportin. In support of this view, it has been shown that forced
overexpressionof ferroportin in cell lines leads to ferritin degrada-
tion concomitantly with iron liberation (DeDomenico et al., 2006).
It implies that the retention of iron in ferritin is rate limiting for
ferroportin-mediated iron export under normal conditions.
Until now, sensing of serum iron by the liver and hepatic hep-
cidin production (Nicolas et al., 2001; Pigeon et al., 2001) werer Inc.
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Figure 6. Induction of Genes Responding to Oxidative
Stress in FthD/D Mice
mRNA levels were measured by RT-PCR for heme-
oxygenase 1 (Hmox1), catalase (Cat), glutathione peroxidase
1 (Gpx1), and superoxide dismutase 1 (Sod1) in 12- and
35-week-old mice. As there were no significant differences
for age or sex, all data were pooled (Fthlox/lox, n = 16; FthD/D,
n = 15). Error bars indicate SD. *p < 0.05, **p < 0.005,
***p < 0.0005.
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ferroportin, which seems to be the limiting step in iron absorp-
tion (Nemeth et al., 2004). We show that ferroportin protein
levels are increased in FthD/D mice, indicating that there exist
mechanisms other than hepcidin that contribute to the accu-
rate regulation of iron export. As ferroportin mRNA levels
were unchanged in FthD/D mice, the ferroportin protein increase
must take place either by increased synthesis or reduced
degradation. The major transcript of ferroportin in duodenum
comprises an IRE in its 50 untranslated region and is transla-
tionally repressed by IRPs (McKie et al., 2000; Liu et al.,
2002), as best demonstrated by the increase of ferroportin
expression in mouse duodenum with a double knockout of
IRP1 and IRP2 (Galy et al., 2008). It seems probable that this
mechanism is responsible for the increase of ferroportin in
the FthD/D mice. Alternatively, we cannot exclude that high
iron and ROS might interfere with ferroportin degradation.
The increase of 59Fe transport observed in FthD/D mice corre-
lates perfectly with the increased ferroportin expression, sug-
gesting that this defect is the main cause of iron accumulation
in these mice. It was previously shown that surface expression
of ferroportin determines iron export from cells both in intestine
(Nemeth et al., 2004) and cell lines with ferroportin overexpres-
sion (De Domenico et al., 2006). We conclude that storage of
excess iron by intestinal ferritin guarantees that ferroportin-
mediated export functions at a defined rate. This seems
to be a prerequisite for hepcidin to reduce ferroportin’s export
capacity by inducing its endocytosis and degradation in
lysosomes.
In the present study, female mice showed consistently higher
hepcidin mRNA induction and higher tissue iron accumulation
than male mice (Figure 3). Similar gender-dependent differences
in these parameters have previously been reported by others
(Courselaud et al., 2004; Vujic Spasic et al., 2007). The difference
was particularly striking in the group of youngest animals
(Figure 3). At 10–18 weeks of age, male mice showed only minor
liver iron stores. The reason for this gender-related difference is
not known, but it might relate to the fact that males show higher
growth rates that direct larger iron fractions away from hepatic
stores to erythropoiesis in order to cover the requirement of
larger blood volume expansion. In addition, C57BL/6 mice are
known to accumulate lower hepatic iron stores as compared to
certain other mouse strains (Courselaud et al., 2004), which
may explain the different kinetics in the formation of iron stores
in liver and spleen. Indeed, spleen iron accumulation, presum-Cell Meably in macrophages, and differences between FthD/D and
Fthlox/lox mice in this tissue became clearly visible only at more
advanced age.
Homozygous ferritin H deletion is embryonic lethal (Darshan
et al., 2009; Ferreira et al., 2000), and thus mice without ferritin
do not exist in nature. However, since we show here that ferritin
expression is essential to prevent excessive iron absorption, one
should consider that any deregulation of intestinal ferritin expres-
sion might represent a cause of hereditary hemochromatosis or
certain forms of anemia. At least two findings suggest such a link.
In human patients, HFE mutations go along with too low ferritin
expression (Francanzani et al., 1989; Pietrangelo et al., 1992,
1995). A Japanese family was identified with a mutation in the
ferritin IRE, exhibiting an increased affinity for IRP1 and hence
a permanently decreased ferritin translation, most likely also
affecting the intestine. This family suffered from iron overload
(Kato et al., 2001). If other causes are excluded, it should be of
interest to analyze intestinal ferritin expression in patients with
chronic forms of iron deficiency or overload.
In conclusion, our present results give credit to early transport
studies in animals (Conrad and Crosby, 1963; Granick, 1946;
Hahn et al., 1943) or intestinal loops (Wheby et al., 1964) and
the concept according towhich the gutmucosa can exert a regu-
lated mucosal resistance to iron absorption. The genetic
evidence presented here confirms the hypothesis formulated
over 65 years ago that such resistance is due to ferritin. Our
observations call for an amendment of the currently prevalent
hypothesis according to which hepcidin interaction with
duodenal ferroportin is sufficient to regulate iron absorption
(Nemeth et al., 2004). We propose that the iron storage function
of duodenal ferritin is required as a sink to keep intracellular free
iron concentrations within a physiological range and to limit
basolateral iron export in the gut (Figure 7).EXPERIMENTAL PROCEDURES
Animals
The work was carried out in conformity with Swiss legal obligations of autho-
rization for animal experimentation. Fthlox/lox mice (Darshan et al., 2009)
were backcrossed to the C57BL/6J strain for ten generations. Villin-Cre
mice (el Marjou et al., 2004) were predominantly in the genetic background
of C57BL/6.
Serum Iron, Total Iron Binding Capacity, and Tissue Iron
Serum iron and total iron binding capacity (TIBC) weremeasuredwith a DCL kit
(Diagnostic Chemicals Limited; Charlotteville, Prince Edward Island, Canada)tabolism 12, 273–282, September 8, 2010 ª2010 Elsevier Inc. 279
Figure 7. Model for the Regulation of Intestinal Iron
Absorption
(A) Iron is absorbed by enterocytes from nutrients and
exported through ferroportin to the bloodstream. Serum iron
or iron-loaded transferrin signal increased iron in circulation
to the liver that responds by secreting hepcidin. Hepcidin
binds to ferroportin, provokes its internalization, and thereby
reduces iron export.
(B) In wild-type mice, the block and downregulation of ferro-
portin induces a transient increase in the free iron pool of
enterocytes and, via IRP inactivation, enhances ferritin
mRNA translation. Ferritin is required to sequester the free
iron. Concomitantly, iron import is diminished by reduced
DMT1 and Dcytb mRNA expression.
(C) In FthD/D mice, free iron cannot be sequestered in ferritin,
which increases the free iron pool. In spite of increased hepci-
din activity and reduced DMT1 and Dcytb mRNA expression,
ferroportin protein is increased. Consequently, more intracel-
lular iron is exported, leading to more extensive iron loading in
liver and spleen.
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calculated from these data. Nonheme iron was measured in wet tissues with
the bathophenanthroline method (Torrance and Bothwell, 1980).
Histology
Tissues were embedded in paraffin, sectioned, and stained with hematoxylin
and eosin (H&E) using standard protocols. Immunohistochemistry was done
on 4 mm tissue sections cut from paraffin-embedded blocks and stained
with either anti-mouse ferritin H at 1:200 dilution (Santa Cruz, CA) or anti-
mouse ferroportin antibody at 1:800 dilution (b196, gift of Nancy Andrews).
The staining was completed with horseradish peroxidase-derivatized goat
anti-rabbit IgG at dilution 1:800 (Vector Labs; Burlingame, CA) and DAB as
a substrate.
Immunoblots
Proteins were extracted from intestinal scrapings by subcellular fractionation
with a Qproteome Cell Compartment Kit (QIAGEN; Hilden, Germany) accord-
ing to the manufacturer’s instructions. Proteins of the cytoplasmic and
membrane fractions were separated by SDS-PAGE and transferred to
a Protran nitrocellulose membrane (Whatman; Dassel, Germany). Membranes
were blockedwith 5%nonfat drymilk (30min) in TBST buffer (100mMTris-HCl
[pH 7.8], 150 mMNaCl, 0.1% Tween-20) and then incubated with a rabbit anti-
ferritin L chain antibody (ab69090, 1:5000, Abcam; Cambridge, UK), a rabbit
anti-SCL40A1 (ferroportin) antibody (NBP1-21502, 1:1500, Novus Biologicals;
Littleton, CO), or a monoclonal mouse anti-b-actin antibody (A3853, 1:2000,
Sigma-Aldrich, Munich) at 4C overnight. Donkey anti-rabbit (NA935V,
1:5000, GE Healthcare; Little Chalfont, UK) and horse anti-mouse (#7076,
1:5000, Cell Signaling; Frankfurt am Main, Germany) HRP-conjugated
secondary antibodies (1.5 hr, 25C), enhanced chemiluminescence reagent,
and film (GE Healthcare) were used to visualize immunoreactive proteins.
The quantification of bands on immunoblots was obtained by measuring the
intensity of the signal in GIMP (http://www.gimp.org) and normalizing ferritin
L or ferroportin to b-actin signals.
Quantification of mRNA Expression
RNA purification, cDNA synthesis, and quantification by real-time PCR using
the LightCycler (Roche Diagnostics; Rotkreuz, Switzerland) were performed
with previously described methods and primers (Darshan et al., 2009). Addi-280 Cell Metabolism 12, 273–282, September 8, 2010 ª2010 Elsevier Inc.tional primers were used for catalase (NM_009804.2) (forward,
GCAGATACCTGTGAACTGTC; reverse, GTAGAATGTCCGC
ACCTGAG), glutathione peroxidase 1 (NM_008160.5) (for-
ward, CCTCAAGTACGTCCGACCTG; reverse, CAATGTCGTT
GCGGCACACC), and superoxide dismutase 1 (NM_011434.1)
(forward, AAGGCCGTGTGCGTGCTGAA; reverse, CAGGTCTCCAACATGCCTCT). Real-time PCR measurements of liver samples were
normalized to mRNA of glyceraldehyde-phosphate dehydrogenase (GAPDH)
and hypoxanthine phosphoribosyl transferase (HPRT) and those of intestinal
samples to GAPDH and b-actin mRNA.
Gel Retardation Assays
Intestinal mucosa was scraped with a glass slide and frozen at 70C. The
tissue was homogenized with a small tissue grinder in 10 mM HEPES
(pH 7.6), 3 mM MgCl2, 40 mM KCl, 1 mM PMSF (Sigma, St. Louis), 0.1%
Triton X-100, and protease inhibitor cocktail ‘‘Complete Mini’’ (Roche). Lysates
were cleared by centrifugation at 12,000 3 g. For gel retardation assays,
a molar excess of 32P-labeled IRE, in vitro transcribed from pSPT-fer (Mu¨llner
et al., 1989), was incubated with 1.5 mg (13) or 12 mg (83) protein extract.
Addition of heparin and RNase T1 were omitted. RNA-protein complexes
were resolved in 6% nondenaturing polyacrylamide gels and quantified with
a phosphorimager (Fuji Medical Systems; Stamford, CT).
Intestinal 59Fe Transport
Iron absorption was measured in mice at the age of 26 weeks, and animals
were under normal food regimen during the experiment. Mice received a single
oral dose by gavage of 100 ml 10 mM FeSO4 in 10 mMHCl, supplemented with
4 mCi 59FeCl3 (NEZ 37, Perkin Elmer, Rodgau, Germany). The applied
59Fe
dose was measured immediately after gavage in a whole-body counter (Typ
AW3, MAB Solutions; Dettenheim, Germany). After 7 days, 59Fe retention
had reached a steady state and was expressed in percent of the applied
59Fe dose. 59Fe activity was also determined in gut and liver.
Statistics
Significance levels were analyzed by unpaired Student’s t test.
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